02487.HK
Cutia Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 0.69
−4.17%Margins
Gross margin
53.6%
EBITDA margin
-66.7%
EBIT margin
-79.5%
Net margin
-84.6%
FCF margin
-69.6%
-39.6%
Return on equity
-26.2%
Return on assets
-26.8%
Return on invested capital
0.28x
Asset turnover
-HKD 267.2M
Cash from operations
HKD 2.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026